Great to hear this news from the team.
It is likely that TBI will be rego'd late March or April at latest. Then ethics approval into trial if they have sourced patients by then.
Q2 will be a MEGA Quarter for IHL. Huge orders for the oils to increase revenue realized in Q2, both OSA and TBI trials occuring.
MASSIVE, SP will make or break depending on what happens in Q2 and this means results will occur in Q3.
This is perfect timing for IHLOB since it expires end of Q3 in September. IHL needs that $10M of funding so the SP needs to run in order for execution to happen.
Tick Tock. Really ain't too long to go.
- Forums
- ASX - By Stock
- IHL
- Ann: Clinical Progress on IHL-216A for TBI and CTE
Ann: Clinical Progress on IHL-216A for TBI and CTE, page-6
-
- There are more pages in this discussion • 127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online